You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 166 No. 1, January 2012 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Editorial
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Pediatrics
 •Pediatrics, Other
 •Quality of Care
 •Patient Safety/ Medical Error
 •Drug Therapy
 •Adverse Effects
 •Pediatric Dosing
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

ONLINE FIRST
Pediatric Polypharmacy

Time to Lock the Medicine Cabinet?

Nancy E. Morden, MD, MPH; David Goodman, MD, MS

Arch Pediatr Adolesc Med. 2012;166(1):91-92. doi:10.1001/archpediatrics.2011.162

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The use of therapeutic agents represents a trade-off between the benefits of symptom relief or disease modification that increase quality or length of life and the risk of short- and long-term adverse effects. While evidence suggests that complex medication combinations greatly increase the odds of incurring an adverse drug event,1-3 US Food and Drug Administration approval generally only requires testing of agents in isolation. As a consequence, we often do not know the net health outcomes associated with diverse and intense medication combinations. This uncertainty is magnified in the care of children for whom efficacy and safety studies are often lacking. Despite this therapeutic uncertainty, pediatric drug use is growing.4 A study in this issue of the Archives5 provides a critical examination of the drug exposure of pediatric inpatients. Polypharmacy is the norm for hospitalized infants and children. Should we be . . . [Full Text of this Article]

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Prevalence of Polypharmacy Exposure Among Hospitalized Children in the United States
Chris Feudtner, Dingwei Dai, Kari R. Hexem, Xianqun Luan, and Talene A. Metjian
Arch Pediatr Adolesc Med. 2012;166(1):9-16.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2012 American Medical Association. All Rights Reserved.